PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 33 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,797 | +16.7% | 41,148 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $178,102 | +495.9% | 35,408 | +628.6% | 0.00% | – |
| Q1 2023 | $29,889 | -76.7% | 4,860 | -49.9% | 0.00% | – |
| Q4 2022 | $128,027 | – | 9,699 | +9599.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 400 | +33.3% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 300 | +50.0% | 0.00% | – |
| Q3 2021 | $3,000 | – | 200 | +700.0% | 0.00% | – |
| Q1 2021 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $396,000 | 0.12% |
| Sofinnova Investments, Inc. | 142,635 | $482,000 | 0.04% |
| INSPIRION WEALTH ADVISORS, LLC | 22,075 | $75,000 | 0.03% |
| Iron Gate Global Advisors LLC | 14,641 | $49,000 | 0.03% |
| REGENTATLANTIC CAPITAL LLC | 18,245 | $62,000 | 0.00% |
| Ellis Investment Partners, LLC | 3,250 | $10,000 | 0.00% |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 45 | $0 | 0.00% |
| Renaissance Technologies | 91,569 | $309,000 | 0.00% |
| BARCLAYS PLC | 1 | $0 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,678 | $46,000 | 0.00% |